Shah, Parantu
Merck Healthcare KGaA, Darmstadt (Germany)
3 papers on CoChatORCID 0000-0003-3014-215X
Most cited papers
- Verified
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery
Computational Drug Discovery MethodsMachine Learning in Materials Science
Cited by 3,228
- Verified
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.
Chauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell
Ubiquitin and proteasome pathwaysMultiple Myeloma Research and Treatments
Cited by 589
- Verified
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Vangamudi, B., Paul, T. A., Shah, P. K., Kost-Alimova, M., Nottebaum, L., Shi, X., Zhan, Y., Leo, E., Mahadeshwar, H. S., Protopopov, A., et al. (2015) · Cancer Research
Chromatin Remodeling and CancerProtein Degradation and Inhibitors
Cited by 281
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free